News
-
-
PRESS RELEASE
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
Moderna discontinues mRNA-1647 development for congenital CMV after Phase 3 trial failure, but continues in bone marrow transplant patients with no impact on financial guidance. Details on the study outcomes and company's future plans -
PRESS RELEASE
NioCorp and IBC Advanced Alloys Successfully Cast Aluminum-Scandium Alloy for Potential Expansion into Al-Sc Alloy Parts
NioCorp Developments Ltd. and IBC Advanced Alloys confirm successful production of 0.2% aluminum-scandium alloy, advancing scandium applications. Scandium-ready for custom part fabrication -
PRESS RELEASE
SMX Tightens Its Core as the World Moves Toward Its Proof-Based Economy (NASDAQ: SMX)
SMX (NASDAQ:SMX) conducts a reverse split to recalibrate its capital structure, positioning for growth. The move aims to enhance perception and streamline focus on its molecular marker technology for global traceability -
-
-
-
-
-